Mitochondria & Energy

Glutathion

Glutathione (GSH) is an endogenous tripeptide and the most important cellular antioxidant. It is taken orally or injected (off-label), with limited to moderate human evidence.

Editorial team ·Updated ·9 Sources ·evidence-rated ·independent & ad-free

Common use from studies

How this peptide is typically used - described, not recommended.

How much
250-1000 mg per day
How often
daily
Administration
Oral

Oral doses of 250 to 1000 mg daily over six months come from a clinical study (a randomized controlled trial) in healthy people. In contrast, information on intravenous (into the vein) and intramuscular (into the muscle) use is based on non-clinically tested practice from forums and compounding pharmacies: they mention 100 to 1200 mg one to three times per week for eight to twelve weeks, with a four-week break. There is no validated protocol for this injection practice; it has not been clinically tested.

This peptide is not injected - a calculation in the injection calculator is not intended here.

As of

What is Glutathione?

Glutathione (GSH) is a tripeptide your body makes from three amino acids: glutamate, cysteine, and glycine (L-γ-glutamyl-L-cysteinyl-glycine). It is the most important cellular antioxidant and is found in nearly every cell at concentrations of 1-10 mM [1]. An unusual γ-bond between the amino acids protects the molecule from being broken down prematurely by enzymes in the cell.

As the primary redox buffer, glutathione protects cells and tissues from oxidative stress caused by free radicals and reactive oxygen species (ROS). It neutralizes oxidants directly and serves as an essential cofactor for protective enzymes like glutathione peroxidase and glutathione S-transferase [2]. The ratio between the reduced form (GSH) and the oxidized form (GSSG) serves as a key indicator for the cell's current redox state.

Glutathione is a peptide active ingredient that is produced endogenously, but can also be taken as an oral dietary supplement or as an injectable preparation. Unlike peptide hormones such as GLP-1 receptor agonists, glutathione acts as a cellular protective peptide without a hormonal control function.

How is Glutathione Used?

Glutathione is primarily taken orally in doses of 250 to 1000 mg daily as a capsule, powder, or liposomal formulation. A randomized, placebo-controlled study in healthy adults shows that a daily dose of 250 mg or 1000 mg over 6 months significantly raises the body's own glutathione stores [3]. Due to enzymatic breakdown in the gastrointestinal tract, oral bioavailability is limited; liposomal formulations or precursors like N-acetylcysteine (NAC) are used to overcome this hurdle.

Injectable glutathione (intravenous or intramuscular) is mainly used in wellness clinics and, in some countries, as a prescription product. In Japan and the Philippines, there is official approval for specific liver diseases [4]. In the USA and the EU, there is no approval as a finished medicinal product, so use is off-label through compounding pharmacies [5]. Due to a lack of safety data and approval, the Philippine FDA explicitly warns against injections for skin lightening [6].

The following table compares the documented routes of administration for glutathione in terms of evidence and dosage:

RouteFormEvidence/ApprovalTypical Dose (Studies/Practice)
OralCapsule, powder, liposomalGRAS (FDA), RCT-proven [3]250-1000 mg/day
IntravenousIV infusion or pushOff-label (US/EU); approved for liver therapy in JP/PH [4]600-1200 mg, 1-2x/week (unproven practice)
IntramuscularIM injectionOff-label; no approval for skin lightening600 mg/week (unproven practice)
TopicalCream, serumOTC products availableVariable

From Vial to Use: Injecting Glutathione

Injectable glutathione comes as a freeze-dried lyophilisate in a vial and is reconstituted with sterile water or isotonic sodium chloride solution before use. The resulting concentration depends on the ratio between the amount of powder and the volume of solvent. In compounding practice, the following typical guidelines are found:

  • Vial size: 600 mg glutathione as lyophilisate
  • Reconstitution with 6 ml sterile water yields 100 mg/ml
  • For a desired amount of 600 mg: withdraw the entire 6 ml
  • For 1200 mg (2 vials): 12 ml, typically as a slow IV infusion over 30-60 minutes

This calculation describes an unproven user practice from the wellness sector and does not provide any evidence of efficacy or safety. A standardized, clinically validated protocol for intravenous use for skin lightening or anti-aging does not exist [6]. For technical basics on mixing and storing peptide solutions, see the guides.

How Does Glutathione Work?

Glutathione works through its free thiol group (-SH) on the cysteine unit as the primary cellular redox buffer, scavenging reactive oxygen species and conjugating harmful electrophiles [2]. The biological protective functions cover five central areas of action:

  • Antioxidant: Neutralizes free radicals, hydrogen peroxide, and lipid peroxides (as a cofactor for glutathione peroxidase)
  • Detoxification: Binds toxins and drug metabolites via glutathione S-transferases, making them excretable
  • Mitochondrial protection: Protects the mitochondria - the cell's powerhouses - from oxidative damage that would otherwise lead to energy loss and cell death
  • Immune function: Supports the function of T-lymphocytes and phagocytes; a glutathione deficiency weakens the immune defense
  • Melanin synthesis: Inhibits tyrosinase, the key enzyme in melanin production - this is the mechanism behind the skin-lightening effect [7]

The intracellular γ-glutamyl cycle ensures the continuous recycling of the molecule: the enzyme glutathione reductase converts oxidized GSSG back into active, reduced GSH using NADPH. This cycle ensures a high antioxidant capacity with a constant amount of peptide.

Glutathione and Skin Lightening - What Does the Evidence Say?

The evidence for glutathione for skin lightening shows moderate but qualitatively limited effects with oral and topical use, while controlled clinical data for intravenous injections are completely lacking. Interest in injectable glutathione is primarily driven by this cosmetic goal.

A systematic review from 2025 documents moderate lightening effects from oral and topical formulations, but rates the quality of evidence as low and points to a lack of long-term safety data [7]. Earlier reviews also concluded that methodological limitations, small sample sizes, and short study durations limit the conclusiveness of existing data [8].

For intravenous glutathione for skin lightening, no published clinical studies exist; an editorial in the South African Medical Journal in 2016 emphasized the insufficient safety data [9]. The Philippine drug authority FDA officially warned in 2019 against intravenous injections for lightening purposes [6].

Glutathione and Aging - The GlyNAC Studies

The combined administration of the precursors glycine and N-acetylcysteine (GlyNAC) boosts the body's own glutathione synthesis and, in a 16-week randomized clinical trial in older adults, improved glutathione levels, mitochondrial function, inflammation markers, insulin resistance, and cognitive performance [10]. Glycine and cysteine are the limiting building blocks of the body's own synthesis. A previous pilot study achieved comparable results [11].

The study results indicate that age-related glutathione deficiencies can be addressed through precursors, although this area of research is still in its early stages.

What Risks and Side Effects Are There?

Oral glutathione has a favorable safety profile and has been classified by the US FDA as GRAS (Generally Recognized As Safe) for food additives [12]. In a 6-month study with 1000 mg/day, no serious adverse events occurred in healthy subjects [3].

For injectable glutathione, risks and side effects are less systematically documented:

  • Local reactions at the injection site (redness, pain, bruising)
  • Allergic reactions, including anaphylaxis (rare)
  • With high-dose IV use: gastrointestinal discomfort, temporary blood pressure changes
  • Long-term risks of high-dose IV use are unknown [9]
  • Special warning: contamination from non-pharmacy production can lead to serious infections - the FDA has documented such incidents [5]

When purchasing peptide preparations, purity and verified origin are crucial factors. The Vendor Radar helps with independent provider checks to avoid contaminated or adulterated batches.

What Is Still Unknown?

  • There are no long-term studies (over 1 year) on oral high-dose supplementation
  • The optimal dose and formulation (reduced vs. liposomal vs. S-acetyl) is not established
  • Controlled clinical studies for IV use for skin lightening are completely lacking [9]
  • The clinical relevance of skin-lightening effects compared to established depigmenting agents is unclear
  • Whether glutathione supplementation provides clinical benefit in healthy people with normal levels is not proven

Glutathione at a Glance

PropertyDetail
StructureTripeptide (L-γ-glutamyl-L-cysteinyl-glycine), MW 307 g/mol
Primary RouteOral (supplement); injectable off-label/clinical
Half-lifeVery short (minutes range in plasma); stable intracellularly through recycling
ApprovalOral: GRAS (FDA); Injectable: approved in JP/PH for liver therapy; not FDA/EMA-approved as a finished drug
EvidenceLimited to moderate human data; RCTs for oral; no controlled studies for IV skin lightening

Glutathione acts as a fundamental protective peptide in every cell of the body. For more information on related peptides and active ingredients, see the Peptide Library, including cellular protective peptides like SS-31 with a mitochondrial target.

Evidence at a glance

Research status
When taken orally, RCT studies show increased levels in healthy individuals [3]; the substance also has GRAS status with the FDA as a food additive [12]. In injectable form, it is approved as a medicine for liver diseases in Japan and the Philippines [4]. In the US and the EU, there is no approval as a finished medicinal product, but compounding on a doctor's prescription is possible [5]. For use in skin lightening, systematic reviews show low evidence quality [7,8], and there is no approval worldwide for this indication.
Human evidence
Taking 250 or 1000 mg of glutathione orally each day can significantly boost your body's glutathione stores over six months, as shown in a randomized controlled trial (RCT) by Richie et al. (2015) in healthy adults [3]. To specifically raise glutathione levels, another RCT by Kumar et al. (2023) tested the precursor combo GlyNAC (glycine and N-acetylcysteine) and found improvements in glutathione levels, mitochondrial function, and cognition in older adults [10]. For skin lightening, systematic reviews show moderate effects with oral or topical use, though the evidence quality is low [7,8]. In contrast, no controlled clinical studies exist for intravenous (IV) administration for skin lightening [9].
Dosages in studies & practice
For oral reduced glutathione, a randomized controlled trial (RCT) in healthy people tested daily doses of 250 mg and 1000 mg over 6 months [3]. Giving it intravenously or intramuscularly (IV/IM) at 600-1200 mg once or twice a week is a wellness practice with no scientific backing and no validated protocol [9]. For the GlyNAC precursors (glycine + NAC), an RCT in older adults looked at a 16-week treatment period [10]. There is no validated human dose for skin lightening.
Risks & side effects
Oral glutathione is generally well tolerated and has FDA GRAS status [12]; a 6-month study with 1000 mg/day found no serious side effects [3]. Injectable glutathione can cause local reactions and, rarely, allergic reactions up to anaphylaxis [5]. There is also a contamination risk when it is not produced in a pharmacy setting [5], while the long-term risks of high-dose intravenous (IV) use are still unknown [9]. The Philippine FDA also warns against intravenous glutathione for skin lightening [6].
Research gaps
For oral high-dose supplementation, long-term studies lasting more than a year are still missing. It is also unclear which formulation works best: no scientific advantage has been proven for the reduced, liposomal, or S-acetyl variants. Controlled studies are also lacking for skin lightening via intravenous infusion (IV), so the clinical relevance of any effects remains unclear. For healthy people with normal baseline levels, there is no evidence that additional intake offers a measurable benefit.

Editorial, sourced from primary literature - not medical advice.

Related peptides

This peptide is not injected - a calculation in the injection calculator is not intended here.

← Back to peptides

The Peptide Signal - monthly, ad-free Learn more